Non-invasive assessment of cardiac condition

The blood vessels that wrap the heart, called coronaries, become sometime partially obstructed, preventing the blood to circulate properly; such condition tend to worsen with time, producing a number of serious health problems including heart failure.  

It has been proven that an instrumental measurement, called Fractional Flow Reserve (FFR), can very effectively recognise the severity of such occlusions, and provide an excellent basis for deciding, in each patient, the most suitable treatment. Unfortunately, the measurement of FFR is and invasive and complex procedure, that only a few hospitals are equipped to perform, and that involve some risks for the patient.

Thus, in spite its efficacy it is rarely used in the clinical practice. A patient-specific vascular modelling technology, emerged from the EU-Heart project, is now being used to estimate the FFR (vFFR) starting from rotational angiography images. After a preliminary on 20 patients was successful, where 19 patients out of 20 were stratified in the same way by FFR and vFFR, the vFFR predictor is now being tested in a mono-centric clinical trial funded by the Wellcome Trust over 100 patients.

Morris PD, Ryan D, Morton AC, Lycett R, Lawford PV, Hose DR, Gunn JP (2013, February). Virtual Fractional Flow Reserve From Coronary Angiography: Modeling the Significance of Coronary Lesions: Results From the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) Study. J Am Coll Cardiol Intv., 6(2), 149-157. doi:10.1016/j.jcin.2012.08.024
Public dissemination: BBC coverage www.youtube.com/watch

Avicenna Alliance news

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up